We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
29 hedge funds and large institutions have $1.21M invested in Cardiff Oncology in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
29% more capital invested
Capital invested by funds: $936K → $1.21M (+$272K)
5.22% more ownership
Funds ownership: 0.07% → 5.29% (+5.2%)
22% less funds holding
Funds holding: 37 → 29 (-8)
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
Holders
29
Holders Change
-8
Holders Change %
-21.62%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
2
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.09M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$857K |
| 3 |
Renaissance Technologies
New York
|
+$538K |
| 4 |
EP
Elkhorn Partners
Omaha,
Nebraska
|
+$181K |
| 5 |
SNB
Security National Bank
Omaha,
Nebraska
|
+$115K |
